Local resection of uveal melanoma

Developments in Ophthalmology

Volumn 49, Issue , 2012, Pages 66-80

  Damato, Bertil E ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INVASION; CANCER STAGING; EYE SURGERY; HUMAN; MELANOMA; METHODOLOGY; PATHOLOGY; TREATMENT OUTCOME; UVEA MELANOMA; UVEA TUMOR;

HUMANS; MELANOMA; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OPHTHALMOLOGIC SURGICAL PROCEDURES; TREATMENT OUTCOME; UVEAL NEOPLASMS;

EID: 84859185147     PISSN: 02503751     EISSN: 16622790     Source Type: Book Series    
DOI: 10.1159/000328261     Document Type: Article

References (36)

1. Arentsen JJ, Green WR: Melanoma of the iris: Report of 72 cases treated surgically. Ophthalmic Surg 1975;6:23-37.
2. Sakellaris D, Goossens C, Tassignon MJ: Customized iris clip anterior chamber intraocular lenses designed for iris reconstruction. Eur J Ophthalmol 2009;19:1084-1087.
3. Damato B, Kacperek A, Chopra M, Sheen MA, Campbell IR, Errington RD: Proton beam radiotherapy of iris melanoma. Int J Radiat Oncol Biol Phys 2005;63:109-115.
4. Shields CL, Shields JA, De Potter P, Singh AD, Hernandez C, Brady LW: Treatment of nonresectable malignant iris tumours with custom designed plaque radiotherapy. Br J Ophthalmol 1995;79:306-312.
5. Damato BE, Foulds WS: Ciliary body tumours and their management. Trans Ophthalmol Soc UK 1986; 105:257-264.
6. Damato EM, Damato B, Sibbring JS, Coupland SE: Ciliary body melanoma with partial deletion of chromosome 3 detected with multiplex ligationdependent probe amplification. Graefes Arch Clin Exp Ophthalmol 2008;246:1637-1640.
7. Foulds WS: Experience of local excision of uveal melanomas. Trans Ophthalmol Soc UK 1977;97: 412-415.
8. Stallard HB: Partial choroidectomy. Br J Ophthalmol 1966;50:660-662.
9. Peyman GA, Juarez CP, Diamond JG, Raichand M: Ten years experience with eye wall resection for uveal malignant melanomas. Ophthalmology 1984; 91:1720-1725.
10. Shields JA, Shields CL: Surgical approach to lamellar sclerouvectomy for posterior uveal melanomas: The 1986 Schoenberg lecture. Ophthalmic Surg 1988;19:774-780.
11. Damato B, Groenewald CP, McGalliard JN, Wong D: Rhegmatogenous retinal detachment after transscleral local resection of choroidal melanoma. Ophthalmology 2002;109:2137-2143.
12. Kim JW, Damato BE, Hiscott P: Noncontiguous tumor recurrence of posterior uveal melanoma after transscleral local resection. Arch Ophthalmol 2002; 120:1659-1664.
13. Damato BE, Paul J, Foulds WS: Predictive factors of visual outcome after local resection of choroidal melanoma. Br J Ophthalmol 1993;77:616-623.
14. Damato BE, Paul J, Foulds WS: Risk factors for metastatic uveal melanoma after trans-scleral local resection. Br J Ophthalmol 1996;80:109-116.
15. Damato BE, Paul J, Foulds WS: Risk factors for residual and recurrent uveal melanoma after transscleral local resection. Br J Ophthalmol 1996;80:102-108.
16. Damato BE, Foulds WS: Surgical resection of choroidal melanoma; in Schachat AP, Ryan SJ (eds): Retina. St Louis, Mosby, Inc, 2006, pp 769-778.
17. Schalenbourg A, Coupland S, Kacperek A, Damato B: Iridocyclectomy for neovascular glaucoma caused by proton-beam radiotherapy of pigmented ciliary adenocarcinoma. Graefes Arch Clin Exp Ophthalmol 2008;246:1499-1501.
18. Damato B, Groenewald C, McGalliard J, Wong D: Endoresection of choroidal melanoma. Br J Ophthalmol 1998;82:213-218.
19. Peyman GA, Cohen SB: Ab interno resection of uveal melanoma. Int Ophthalmol 1986;9:29-36.
20. Damato B: Choroidal melanoma endoresection, dandelions and allegory-based medicine. Br J Ophthalmol 2008;92:1013-1014.
21. Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jockel KH, Becher R: Prognostic implications of monosomy 3 in uveal melanoma. Lancet 1996;347: 1222-1225.
22. Onken MD, Worley LA, Ehlers JP, Harbour JW: Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 2004;64:7205-7209.
23. Damato BE, Dopierala JA, Coupland SE: Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification. Clin Cancer Res 2010;16:6083-6092.
24. Damato B, Wong D, Green FD, Mackenzie JM: Intrascleral recurrence of uveal melanoma after transretinal 'endoresection'. Br J Ophthalmol 2001; 85:114-115.
25. Hadden PW, Hiscott PS, Damato BE: Histopathology of eyes enucleated after endoresection of choroidal melanoma. Ophthalmology 2004;111:154-160.
26. Garcia-Arumi J, Zapata MA, Balaguer O, Fonollosa A, Boixadera A, Martinez-Castillo V: Endoresection in high posterior choroidal melanomas: Long-term outcome. Br J Ophthalmol 2008;92:1040-1045.
27. Schilling H, Bornfeld N, Talies S, et al: Endoresection of large uveal melanomas after pretreatment by single-dose stereotactic convergence irradiation with the leksell gamma knife -First experience on 46 cases. Klin Monatsbl Augenheilkd 2006;223:513-520.
28. Bechrakis NE, Hocht S, Martus P, Kreusel KM, Heese J, Foerster MH: Endoresection following proton beam irradiation of large uveal melanomas. Ophthalmologe 2004;101:370-376.
29. Zimmerman LE, McLean IW, Foster WD: Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells. Br J Ophthalmol 1978;62:420-425.
30. Foulds WS, Damato BE, Burton RL: Local resection versus enucleation in the management of choroidal melanoma. Eye 1987;1:676-679.
31. Parrella P, Sidransky D, Merbs SL: Allelotype of posterior uveal melanoma: Implications for a bifurcated tumor progression pathway. Cancer Res 1999;59: 3032-3037.
32. Tschentscher F, Husing J, Holter T, et al: Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Cancer Res 2003;63: 2578-2584.
33. Callejo SA, Dopierala J, Coupland SE, Damato B: Sudden growth of a choroidal melanoma and multiplex ligation-dependent probe amplification findings suggesting late transformation to monosomy 3 type. Arch Ophthalmol 2011;129:958-960.
34. Bechrakis NE, Sehu KW, Lee WR, Damato BE, Foerster MH: Transformation of cell type in uveal melanomas: A quantitative histologic analysis. Arch Ophthalmol 2000;118:1406-1412.
35. Gragoudas ES, Lane AM, Munzenrider J, Egan KM, Li W: Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans Am Ophthalmol Soc 2002;100:43-48.
36. Damato B: Legacy of the collaborative ocular melanoma study. Arch Ophthalmol 2007;125:966-968.